|
dbGaP Submitter Subject ID (ID2) | Coriell Sample ID | Consent | Control | Gender | Race | Age | Baseline Max AMD Severity | Final Max AMD Severity |
AR2_0030 | ED148302 | General Research Use | No | Female | White | 65 | 11b - Neovascular AMD with end-stage disease (e.g., definite disciform scar, or photocoagulation scar), or two or more of the following five characteristics of neovascular AMD: SSR detachment, PED, subretinal/sub-RPE hemorrhage, hard exudate, or fibrous tissue | 11b - Neovascular AMD with end-stage disease (e.g., definite disciform scar, or photocoagulation scar), or two or more of the following five characteristics of neovascular AMD: SSR detachment, PED, subretinal/sub-RPE hemorrhage, hard exudate, or fibrous tissue |
AR2_0044 | ED149316 | General Research Use | No | Female | White | 68 | 7 - AREDS AMD Severity Scale Step 7 | 11b - Neovascular AMD with end-stage disease (e.g., definite disciform scar, or photocoagulation scar), or two or more of the following five characteristics of neovascular AMD: SSR detachment, PED, subretinal/sub-RPE hemorrhage, hard exudate, or fibrous tissue |
AR2_0076 | ED148592 | General Research Use | No | Female | White | 65 | 6 - AREDS AMD Severity Scale Step 6 | 7 - AREDS AMD Severity Scale Step 7 |
AR2_0088 | ED148286 | General Research Use | No | Female | White | 68 | 8 - AREDS AMD Severity Scale Step 8 | 11b - Neovascular AMD with end-stage disease (e.g., definite disciform scar, or photocoagulation scar), or two or more of the following five characteristics of neovascular AMD: SSR detachment, PED, subretinal/sub-RPE hemorrhage, hard exudate, or fibrous tissue |
AR2_0218 | ED149055 | General Research Use | No | Female | White | 65 | 7 - AREDS AMD Severity Scale Step 7 | 10 - Central GA |
AR2_0286 | ED149189 | General Research Use | No | Male | White | 69 | 8 - AREDS AMD Severity Scale Step 8 | 7 - AREDS AMD Severity Scale Step 7 |
AR2_0300 | ED148558 | General Research Use | No | Female | White | 65 | 6 - AREDS AMD Severity Scale Step 6 | 7 - AREDS AMD Severity Scale Step 7 |
AR2_0320 | ED149890 | General Research Use | No | Female | White | 65 | 7 - AREDS AMD Severity Scale Step 7 | 7 - AREDS AMD Severity Scale Step 7 |
AR2_0338 | ED148922 | General Research Use | No | Female | White | 66 | 11b - Neovascular AMD with end-stage disease (e.g., definite disciform scar, or photocoagulation scar), or two or more of the following five characteristics of neovascular AMD: SSR detachment, PED, subretinal/sub-RPE hemorrhage, hard exudate, or fibrous tissue | 11b - Neovascular AMD with end-stage disease (e.g., definite disciform scar, or photocoagulation scar), or two or more of the following five characteristics of neovascular AMD: SSR detachment, PED, subretinal/sub-RPE hemorrhage, hard exudate, or fibrous tissue |
AR2_0344 | ED149324 | General Research Use | No | Male | White | 69 | 11b - Neovascular AMD with end-stage disease (e.g., definite disciform scar, or photocoagulation scar), or two or more of the following five characteristics of neovascular AMD: SSR detachment, PED, subretinal/sub-RPE hemorrhage, hard exudate, or fibrous tissue | 11b - Neovascular AMD with end-stage disease (e.g., definite disciform scar, or photocoagulation scar), or two or more of the following five characteristics of neovascular AMD: SSR detachment, PED, subretinal/sub-RPE hemorrhage, hard exudate, or fibrous tissue |
AR2_0390 | ED148833 | General Research Use | No | Female | White | 66 | 11b - Neovascular AMD with end-stage disease (e.g., definite disciform scar, or photocoagulation scar), or two or more of the following five characteristics of neovascular AMD: SSR detachment, PED, subretinal/sub-RPE hemorrhage, hard exudate, or fibrous tissue | 11b - Neovascular AMD with end-stage disease (e.g., definite disciform scar, or photocoagulation scar), or two or more of the following five characteristics of neovascular AMD: SSR detachment, PED, subretinal/sub-RPE hemorrhage, hard exudate, or fibrous tissue |
AR2_0403 | ED149705 | General Research Use | No | Female | White | 67 | 8 - AREDS AMD Severity Scale Step 7 | 11b - Neovascular AMD with end-stage disease (e.g., definite disciform scar, or photocoagulation scar), or two or more of the following five characteristics of neovascular AMD: SSR detachment, PED, subretinal/sub-RPE hemorrhage, hard exudate, or fibrous tissue |
AR2_0406 | ED149918 | General Research Use | No | Female | White | 68 | 6 - AREDS AMD Severity Scale Step 6 | 7 - AREDS AMD Severity Scale Step 7 |
AR2_0468 | ED148507 | Eye Disease Only | No | Female | White | 69 | 6 - AREDS AMD Severity Scale Step 6 | 7 - AREDS AMD Severity Scale Step 7 |
AR2_0522 | ED148977 | General Research Use | No | Male | White | 68 | 7 - AREDS AMD Severity Scale Step 7 | 10 - Central GA |
AR2_0556 | ED148868 | Eye Disease Only | No | Female | White | 65 | 11b - Neovascular AMD with end-stage disease (e.g., definite disciform scar, or photocoagulation scar), or two or more of the following five characteristics of neovascular AMD: SSR detachment, PED, subretinal/sub-RPE hemorrhage, hard exudate, or fibrous tissue | 11b - Neovascular AMD with end-stage disease (e.g., definite disciform scar, or photocoagulation scar), or two or more of the following five characteristics of neovascular AMD: SSR detachment, PED, subretinal/sub-RPE hemorrhage, hard exudate, or fibrous tissue |
AR2_0627 | ED149202 | General Research Use | No | Male | White | 69 | 5 - AREDS AMD Severity Scale Step 5 | 7 - AREDS AMD Severity Scale Step 7 |
AR2_0698 | ED148658 | General Research Use | No | Male | White | 69 | 4 - AREDS AMD Severity Scale Step 2 | 8 - AREDS AMD Severity Scale Step 8 |
AR2_0754 | ED148545 | General Research Use | No | Male | White | 67 | 7 - AREDS AMD Severity Scale Step 6 | 8 - AREDS AMD Severity Scale Step 8 |
AR2_0756 | ED150009 | General Research Use | No | Male | White | 69 | 5 - AREDS AMD Severity Scale Step 5 | 6 - AREDS AMD Severity Scale Step 6 |